BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/15/2018 9:13:16 AM | Browse: 1273 | Download: 2075
 |
Received |
|
2018-02-07 09:47 |
|
Peer-Review Started |
|
2018-02-07 09:57 |
|
First Decision by Editorial Office Director |
|
2018-02-23 19:31 |
|
Return for Revision |
|
2018-02-24 09:41 |
|
Revised |
|
2018-03-09 12:05 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-03-22 08:46 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-03-29 14:08 |
|
Articles in Press |
|
2018-03-29 14:08 |
|
Edit the Manuscript by Language Editor |
|
2018-05-24 13:59 |
|
Typeset the Manuscript |
|
2018-06-13 08:41 |
|
Publish the Manuscript Online |
|
2018-06-15 09:13 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lin-Zhong Zhu, Song Xu and Hai-Long Qian |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Key R&D Program of China |
2016YFC0106604 |
| National Natural Science Foundation of China |
81502591 |
|
| Corresponding Author |
Hai-Long Qian, MD, Doctor, Doctor, Department of Interventional Therapy, Baotou Cancer Hospital, 18 Tuanjie Street, Qingshan District, Baotou 014030, Inner Mongolia Autonomous Region, China. hailongqian@163.com |
| Key Words |
Transarterial embolization; Oxaliplatin; Major portal vein tumor thrombus; Raltitrexed; Continuous hepatic arterial infusion chemotherapy |
| Core Tip |
We analyzed the pharmacokinetic and pharmacodynamic characteristics of continuous hepatic arterial infusion of oxaliplatin and raltitrexed to aid interventional radiologist in determining a more accurate infusion protocol. The clinical protocol based on the pharmacokinetics study in a swine model and the pharmacodynamics study in tumor cell lines was shown to be effective and safe in hepatocellular carcinoma with main portal vein tumor thrombus. |
| Publish Date |
2018-06-15 09:13 |
| Citation |
Zhu LZ, Xu S, Qian HL. Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus. World J Gastroenterol 2018; 24(23): 2501-2507 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i23/2501.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i23.2501 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
